SEARCH LOCATION: Global CONTACT US NEWSROOM INVESTORS Enabling people with life-altering conditions to lead better lives. WHO WE ARE PATIENTS R&D PRODUCTS CAREERS LATEST NEWS Non-Stimulant for ADHD Approved in Europe Shire’s non-stimulant ADHD treatment receives approval in EU for children & adolescents. Learn more We're now on Twitter! Follow @Shireplc for company news, culture, financial performance and more! Visit Shire on Twitter Presentation- Second Quarter 2015 Results View Shire's Q2 2015 Earnings presentation Click here INNOVATION SERIES SPOTLIGHT ON GAUCHER STUDENT SCHOLARSHIPS JOIN US S06661 07/2015 | INTSP/C-ANPROM/CORP/15/0006 QUICK LINKS Corporate Brand Partnerships Patient Services Pipeline Responsibility Contact Us Home LEGAL Privacy Policy Cookies Disclaimer Legal Notice Safe Harbor STAY CONNECTED RSS Feed Sign Up for Email or SMS Alerts Website Feedback © Shire 2015 All Rights Reserved Cookie Use Notification The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our cookie notice for more information on the cookies we user and how to delete or block the use of cookies. LEARN MORE CONTINUE DISAGREE